Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICLE 2022 | Highlights from ICLE 2022

Tuna Mutis, MD, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, provides his highlights from the International Conference on Lymphocyte Engineering (ICLE) 2022, including presentations on the latest in T-cell receptor engineering as well as novel developments in the field of HLA-independent T-cell (HIT) receptors that will aim to optimize current chimeric antigen receptor (CAR) T-cell therapies. This interview took place at ICLE 2022.